Abstract
Abstract 3960
Poster Board III-896
Rare cases of histiocytic sarcoma (HS) have been reported in association with indolent small B-cell neoplasms, either concurring with or following a small B-cell lymphoma. The biologic relationship between these two morphologically and immunophenotypically distinct neoplasms in same patients remains unclear, though recent data suggest a possible “transdifferentiation” from follicular lymphoma (FL) to HS.
We investigate the clonal relationship in two cases of B-cell lymphoma with subsequent HS, using immunohistochemical stains, PCR-based immunoglobulin heavy chain (IGH) gene rearrangement/sequencing analysis and interphase FISH study on formalin fixed, paraffin-imbedded tissue sections.
Case 1 is a 62-year-old female with splenic marginal zone lymphoma (SMZL) who developed HS in a groin lymph node one year after the diagnosis of SMZL. PCR/sequence analysis of IGH gene showed a monoclonal rearrangement carrying identical DNA sequences of PCR products from the spleen with SMZL and the lymph node with HS. Case 2 is a 61-year-old female with a remote history of FL who developed supraclavicular lymphadenopathy and multiple other infiltrating foci. A supraclavicular lymph node biopsy demonstrated HS. PCR analysis detected a monoclonal rearrangement of the IGH gene and interphase FISH analysis revealed IGH/BCL-2 fusion, a genetic hallmark for FL. Although negative for other B-cell associated antigen markers, HSs show partial retention of primary neoplasms B-cell lymphomas' immunoprofiles, including expression of Oct-2 in both cases, and expression of bcl-6 and enhanced expression of bcl-2 in case 2.
The data provide a genotypic evidence of common clonal origin between mature B-cell lymphoma and subsequent HS in the same patients, suggesting “transdifferentiation” to HS could occur in other small B-cell lymphoma, in addition to FL. The transformed HSs might have incompletely inherited primary neoplasms' expression signatures by retaining B-cell lymphomas' characteristic immunoprofile to certain extent. The exact mechanism governing the conversion of mature B-cell lymphoma to HS is largely a mystery and remains to be elucidated by more scientific studies, though a few pathways have been proposed for the process, including transdifferentiation, dedifferentiation and common progenitor models.
. | Case 1 . | Case 2 . |
---|---|---|
Primary neoplasm . | SMZL . | FL . |
Interval between 1st and 2nd neoplasm (yrs) | 1 | 17 |
- | - | |
Immunohistochemical and other studies | ||
Leukocyte common antigen | ||
CD45 | W+ | W+ |
B-cell antigens | ||
CD20 | - | - |
CD79a | - | - |
Pax-5 | - | - |
OCT-2 | W/M+ | W+ |
BOB-1 | - | - |
T-cell antigens | ||
CD2 | - | - |
CD3 | - | - |
CD5 | - | - |
CD4 | W+ | W+ |
CD8 | - | - |
Follicle center antigens | ||
CD10 | - | - |
Bcl-6 | - | W/M+ |
Histiocytic/dendritic cell antigens | ||
CD68 | + | + |
CD163 | + | + |
CD1a | - | - |
CD21 | - | - |
CD23 | - | - |
CD35 | - | nd |
S100 | F+ | F+ |
Lysozyme | F+ | F+ |
Others | ||
MPO | - | - |
Bcl-2 | -/W+ | Br+ |
Ki-67 | 20-30% | 15-25% |
EBER ISH | - | - |
Genetic studies | ||
IGH gene rearrangement | Clonal | Clonal |
FISH for IGH/BCL-2 | - | + |
. | Case 1 . | Case 2 . |
---|---|---|
Primary neoplasm . | SMZL . | FL . |
Interval between 1st and 2nd neoplasm (yrs) | 1 | 17 |
- | - | |
Immunohistochemical and other studies | ||
Leukocyte common antigen | ||
CD45 | W+ | W+ |
B-cell antigens | ||
CD20 | - | - |
CD79a | - | - |
Pax-5 | - | - |
OCT-2 | W/M+ | W+ |
BOB-1 | - | - |
T-cell antigens | ||
CD2 | - | - |
CD3 | - | - |
CD5 | - | - |
CD4 | W+ | W+ |
CD8 | - | - |
Follicle center antigens | ||
CD10 | - | - |
Bcl-6 | - | W/M+ |
Histiocytic/dendritic cell antigens | ||
CD68 | + | + |
CD163 | + | + |
CD1a | - | - |
CD21 | - | - |
CD23 | - | - |
CD35 | - | nd |
S100 | F+ | F+ |
Lysozyme | F+ | F+ |
Others | ||
MPO | - | - |
Bcl-2 | -/W+ | Br+ |
Ki-67 | 20-30% | 15-25% |
EBER ISH | - | - |
Genetic studies | ||
IGH gene rearrangement | Clonal | Clonal |
FISH for IGH/BCL-2 | - | + |
SMZL, splenic marginal zone lymphoma; FL, follicular lymphoma; +, positive; W+, weakly positive; W/M+, weakly to moderately positive; F+, focally positive; Br+, brightly positive; -, negative; nd, not done
No relevant conflicts of interest to declare.
Author notes
Asterisk with author names denotes non-ASH members.